WIN-Partners Co., Ltd.

TSE:3183 Stock Report

Market Cap: JP¥39.1b

WIN-Partners Past Earnings Performance

Past criteria checks 1/6

WIN-Partners's earnings have been declining at an average annual rate of -0.4%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 4.5% per year. WIN-Partners's return on equity is 8.7%, and it has net margins of 2.4%.

Key information

-0.4%

Earnings growth rate

-0.1%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate4.5%
Return on equity8.7%
Net Margin2.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings

Nov 26
There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings

We Think You Can Look Beyond WIN-Partners' (TSE:3183) Lackluster Earnings

May 22
We Think You Can Look Beyond WIN-Partners' (TSE:3183) Lackluster Earnings

Recent updates

There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings

Nov 26
There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings

WIN-Partners' (TSE:3183) Dividend Will Be Increased To ¥51.00

Nov 08
WIN-Partners' (TSE:3183) Dividend Will Be Increased To ¥51.00

We Think You Can Look Beyond WIN-Partners' (TSE:3183) Lackluster Earnings

May 22
We Think You Can Look Beyond WIN-Partners' (TSE:3183) Lackluster Earnings

Revenue & Expenses Breakdown

How WIN-Partners makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:3183 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2480,8381,9797,0170
30 Jun 2479,2851,9416,9750
31 Mar 2477,0641,8356,9070
31 Dec 2374,3961,6946,8110
30 Sep 2372,4172,0086,6480
30 Jun 2371,4931,9376,4810
31 Mar 2370,8542,0476,1920
31 Dec 2268,8881,9206,1330
30 Sep 2268,8631,7735,9610
30 Jun 2267,6991,8665,8130
31 Mar 2266,3911,8315,7570
31 Dec 2166,5082,0075,6100
30 Sep 2165,3841,7675,5910
30 Jun 2164,7161,7065,5720
31 Mar 2162,1231,5405,4880
31 Dec 2060,4161,4185,3600
30 Sep 2059,2761,3975,3840
30 Jun 2060,3041,5525,3890
31 Mar 2064,5371,8725,5220
31 Dec 1967,7262,2395,4370
30 Sep 1971,0562,7915,4060
30 Jun 1970,9762,7745,3930
31 Mar 1969,7752,6405,3510
31 Dec 1866,8452,5845,2830
30 Sep 1864,9422,8835,2550
30 Jun 1864,1362,8555,1050
31 Mar 1862,8323,0054,9000
31 Dec 1762,1742,8874,8620
30 Sep 1759,8002,1774,6480
30 Jun 1758,6412,2004,5470
31 Mar 1757,7602,1414,4930
31 Dec 1656,6272,1484,3570
30 Sep 1655,9892,1564,3120
30 Jun 1655,2552,1214,2890
31 Mar 1654,1472,1114,2990
31 Dec 1553,6412,0084,2540
30 Sep 1552,8391,9214,2260
30 Jun 1551,5101,8704,1820
31 Mar 1550,5581,6904,0960
31 Dec 1451,0211,5684,0780
30 Sep 1451,1861,5254,0060
30 Jun 1450,6331,4403,9720
31 Mar 1449,8261,8403,9150

Quality Earnings: 3183 has high quality earnings.

Growing Profit Margin: 3183's current net profit margins (2.4%) are lower than last year (2.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 3183's earnings have declined by 0.4% per year over the past 5 years.

Accelerating Growth: 3183's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3183 had negative earnings growth (-1.4%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).

Return on Equity

High ROE: 3183's Return on Equity (8.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 13:04
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WIN-Partners Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution